Status:
UNKNOWN
The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff
Lead Sponsor:
Ant Shepherd
Collaborating Sponsors:
Hampshire Hospitals NHS Foundation Trust
Conditions:
Heart Diseases
Eligibility:
All Genders
18+ years
Brief Summary
What are the experiences of staff and participants in phase 3 cardiac rehabilitation during the Covid-19 pandemic, and what impacts have adapted delivery had on participants' physical activity levels,...
Detailed Description
Cardiovascular disease (CVD) causes 17.9 million deaths globally each year, an estimated 31% of all deaths worldwide. Individuals diagnosed with CVD (e.g., acute coronary syndrome) are typically refer...
Eligibility Criteria
Inclusion
- Aged 18 years or over
- Staff and participants participating in Phase 3 CR
- Able to give informed consent
- Willing and able to undertake the interview, diary, questionnaire and accelerometer processes
Exclusion
- Aged \<18 years
- Not participating in Phase 3 CR
- Any individuals who are unable to represent their own interests or are particularly susceptible to coercion (vulnerable individuals), and are therefore unable to give informed consent
- If individuals have difficulties in adequately understanding written or verbal information in English, as the study doesn't have funding for a translator or interpreter
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04740489
Start Date
February 1 2021
End Date
June 1 2022
Last Update
February 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.